Guest User 6/20/24 Guest User 6/20/24 Set the Course from Idea to Clinical Development for Innovative Therapies: Key Steps Read More Michael Firgens 4/4/24 Michael Firgens 4/4/24 Navigating FDA Type B Meetings with CBER: A Comprehensive Guide Read More Michael Firgens 3/19/24 Michael Firgens 3/19/24 The Investigational Medicinal Product Dossier (IMPD): Essential CTA Document and Guide for Your Biopharmaceutical Development Program Read More Michael Firgens 2/27/24 Michael Firgens 2/27/24 Accelerate Your Cell and Gene Therapy Development Through Regulatory Expedited Programs - PRIME, RMAT, ILAP & Co. Read More Michael Firgens 12/25/22 Michael Firgens 12/25/22 Drug Repurposing: Opportunities for Developing Drugs Faster, Safer, Cheaper in New Therapeutic Areas Read More Michael Firgens 8/21/22 Michael Firgens 8/21/22 Guiding Principles for the Development of Highly Innovative Biopharmaceuticals – an Overview from a Program Management Perspective Read More Michael Firgens 3/21/21 Michael Firgens 3/21/21 Rare Diseases: Accelerate Your Product Development Through Orphan Designation Read More Michael Firgens 3/14/21 Michael Firgens 3/14/21 Benefit from EMA’s Innovation Support and Incentives for Small Biotech and Pharma Businesses Read More Michael Firgens 12/27/20 Michael Firgens 12/27/20 How to Tackle Tech Transfer Projects for Biopharmaceuticals Read More CONTACT US How can we help you? Name * First Name Last Name Email * Message * Thank you!
Guest User 6/20/24 Guest User 6/20/24 Set the Course from Idea to Clinical Development for Innovative Therapies: Key Steps Read More
Michael Firgens 4/4/24 Michael Firgens 4/4/24 Navigating FDA Type B Meetings with CBER: A Comprehensive Guide Read More
Michael Firgens 3/19/24 Michael Firgens 3/19/24 The Investigational Medicinal Product Dossier (IMPD): Essential CTA Document and Guide for Your Biopharmaceutical Development Program Read More
Michael Firgens 2/27/24 Michael Firgens 2/27/24 Accelerate Your Cell and Gene Therapy Development Through Regulatory Expedited Programs - PRIME, RMAT, ILAP & Co. Read More
Michael Firgens 12/25/22 Michael Firgens 12/25/22 Drug Repurposing: Opportunities for Developing Drugs Faster, Safer, Cheaper in New Therapeutic Areas Read More
Michael Firgens 8/21/22 Michael Firgens 8/21/22 Guiding Principles for the Development of Highly Innovative Biopharmaceuticals – an Overview from a Program Management Perspective Read More
Michael Firgens 3/21/21 Michael Firgens 3/21/21 Rare Diseases: Accelerate Your Product Development Through Orphan Designation Read More
Michael Firgens 3/14/21 Michael Firgens 3/14/21 Benefit from EMA’s Innovation Support and Incentives for Small Biotech and Pharma Businesses Read More
Michael Firgens 12/27/20 Michael Firgens 12/27/20 How to Tackle Tech Transfer Projects for Biopharmaceuticals Read More